Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Pro-Dex Inc.

Start price
Target price
Perf. (%)
€13.90
07.10.23
-
07.10.24
26.62%
06.06.24

buy
Trinity Biotech ADR

Start price
Target price
Perf. (%)
€0.41
07.10.23
-
07.10.24
0.00%
22.02.24

buy
Sutro Biopharma Inc

Start price
Target price
Perf. (%)
€3.16
05.10.23
-
05.10.24
13.92%
06.06.24

buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€43.60
04.10.23
€65.81
04.10.24
-55.85%
07.06.24

buy
Ocular Therapeutix Inc.

Start price
Target price
Perf. (%)
€2.76
04.10.23
€11.40
04.10.24
75.14%
07.06.24

buy
Cocrystal Pharma Inc.

Start price
Target price
Perf. (%)
€1.79
04.10.23
€11.40
04.10.24
15.08%
06.06.24

buy
Accuray Inc.

Start price
Target price
Perf. (%)
€2.76
04.10.23
€7.12
04.10.24
-39.86%
07.06.24

Paion AG

Start price
Target price
Perf. (%)
€0.68
04.10.23
€0.000
04.10.24
-
11.04.23

Innovative
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Strong uniques
buy
Pacira Pharmaceuticals

Start price
Target price
Perf. (%)
€27.40
03.10.23
€65.04
03.10.24
0.00%
06.06.24

buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€0.94
02.10.23
€8.55
02.10.24
174.15%
07.06.24

buy
AB Science S.A.

Start price
Target price
Perf. (%)
€2.67
02.10.23
-
02.10.24
-51.22%
07.06.24

Could be worthwhile Investment >10% per year
buy
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.41
01.10.23
€3.00
31.01.26
-65.45%
07.06.24

Could be very worthwhile Investment >20% year
Avinger Inc.

Start price
Target price
Perf. (%)
€0.34
01.10.23
-
01.10.24
0.00%
20.11.23

Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€1.84
01.10.23
€1.20
01.10.24
-14.13%
06.06.24

ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
US Physical Therapy Inc.

Start price
Target price
Perf. (%)
€86.50
30.09.23
-
30.09.24
6.02%
06.06.24

buy
Addus Homecare Corp.

Start price
Target price
Perf. (%)
€79.50
30.09.23
-
30.09.24
29.56%
06.06.24

Enanta Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€10.70
30.09.23
-
30.09.24
12.15%
06.06.24

Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€0.14
30.09.23
-
30.09.24
-
08.09.23

buy
Krystal Biotech

Start price
Target price
Perf. (%)
€111.00
30.09.23
-
30.09.24
37.12%
07.06.24

buy
Atricure Inc.

Start price
Target price
Perf. (%)
€59.50
29.09.23
€52.82
29.09.24
-
30.09.21

buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.42
28.09.23
€6.63
28.09.24
-51.37%
07.06.24

buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€7.97
28.09.23
€10.46
28.09.24
-76.69%
07.06.24

buy
Motus GI Holdings Inc.

Start price
Target price
Perf. (%)
€0.41
27.09.23
€2.37
27.09.24
35.14%
20.11.23

buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.11
27.09.23
€3.55
27.09.24
-11.33%
07.06.24

buy
Verastem Inc.

Start price
Target price
Perf. (%)
€7.60
27.09.23
€19.90
27.09.24
-55.26%
07.06.24